Market revenue in 2023 | USD 1,607.0 million |
Market revenue in 2030 | USD 3,182.9 million |
Growth rate | 10.3% (CAGR from 2023 to 2030) |
Largest segment | Reagents & kits |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & kits, Services, Instruments |
Key market players worldwide | Charles River Laboratories International Inc, BSL-BIOSERVICE Scientific Laboratories GmbH, Merck KGaA, Samsung BioLogics, Sartorius AG, Eurofins Scientific SE, SGS AG, Thermo Fisher Scientific Inc, BioMerieux SA, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological safety testing products and services market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 39.88% in 2023. Horizon Databook has segmented the North America biological safety testing products and services market based on reagents & kits, services, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
In 2015, North America captured a substantial share of 36.2% of the regional biological safety testing sector. The share attained by this region is primarily a consequence of the presence of prominent market players undertaking extensive growth expansion strategies.
The dominant share is attributed to high investment in the biotechnology sector and its increasing adoption in cancer research and the development of new biologics, vaccines, and drugs. Moreover, the increasing number of R&D investments initiated by the companies is one of the key potential growth factors responsible for the sizeable share garnered by North America.
Furthermore, the increasing chronic disease burden in this region is anticipated to drive the use of advanced technologies amongst researchers and healthcare professionals, which in turn is further anticipated to widen the scope for growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biological safety testing products and services market , including forecasts for subscribers. This continent databook contains high-level insights into North America biological safety testing products and services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account